2,3-dinor, 6-keto-PGF1alpha

2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha

MeSH term MeSH ID Detail
Pulmonary Heart Disease D011660 2 associated lipids
Diseases in Twins D004200 4 associated lipids
Tibial Fractures D013978 4 associated lipids
Bartter Syndrome D001477 5 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Down Syndrome D004314 18 associated lipids
Pregnancy Complications D011248 19 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Ascites D001201 25 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Endometriosis D004715 29 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Thrombosis D013927 49 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Per page 10 20 50 | Total 25

NCBI Entrez Crosslinks

All references with 2,3-dinor, 6-keto-PGF1alpha

Download all related citations
Per page 10 20 50 100 | Total 191
Authors Title Published Journal PubMed Link
Koivisto VA et al. Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. 1989 Diabetes Care pmid:2507264
Lupinetti MD et al. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. 1989 Am. Rev. Respir. Dis. pmid:2508524
Ritter JM et al. Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. 1989 Br J Clin Pharmacol pmid:2590611
Ruth V et al. Urinary excretion of prostacyclin metabolites in infants born after maternal preeclampsia or with birth asphyxia. 1989 Biol. Neonate pmid:2506939
Fitzgerald DJ et al. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. 1988 J. Clin. Invest. pmid:3183064
Balazy M et al. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. 1988 Prostaglandins pmid:3070630
Vesterqvist O et al. In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. 1988 Scand. J. Clin. Lab. Invest. pmid:3375779
Wennmalm A et al. Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. 1988 Clin Physiol pmid:3402185
Gréen K et al. Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus. 1988 Acta Endocrinol. pmid:3291538
Alessandrini P et al. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. 1988 N. Engl. J. Med. pmid:3292913
Ylikorkala O et al. Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. 1988 Obstet Gynecol pmid:3275910
Lassila R et al. Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. 1988 BMJ pmid:3142565
Vericel E et al. Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. 1988 Thromb. Res. pmid:3129819
Minuz P et al. Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. 1988 Hypertension pmid:3290103
Seyberth HW et al. Excretion of primary prostanoids and their metabolites during acute volume expansion. 1988 Prostaglandins pmid:3163156
Hamm CW et al. Biochemical evidence of platelet activation in patients with persistent unstable angina. 1987 J. Am. Coll. Cardiol. pmid:3668113
Nowak J et al. Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. 1987 Am. J. Physiol. pmid:3548440
Cibattoni G et al. Effects of sulindac on renal and extrarenal eicosanoid synthesis. 1987 Clin. Pharmacol. Ther. pmid:3549118
Fitzgerald DJ et al. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. 1987 Circulation pmid:3552297
Vesterqvist O et al. Thromboxane and prostacyclin formation in patients with deep vein thrombosis. 1987 Thromb. Res. pmid:3554598